)
Company Research25 Mar 2024
Companies That Had Their IPO in 1997: Tech and Internet Fever
An overview of the IPO landscape and stock market sentiment as the dot com bubble slowly started to take shape.
Eurofins Scientific
Eurofins Scientific (ERF) investor relations material
Eurofins Scientific Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary29 Jan, 2026
Executive summary
Achieved or exceeded all FY 2025 objectives, including 24% EPS growth, 5% revenue growth, margin expansion, and strong free cash flow, confirming 2027 targets and marking progress in a five-year plan for a global digital laboratory network.
Organic growth accelerated through the year, with Q4 showing the highest rate and EPS growth reaching 30% in the second half.
Significant investments in automation, AI, IT, and infrastructure are driving improved operating leverage, with benefits from a five-year investment program starting to materialize.
All regular capex and M&A investments were fully funded by operating cash flow, with surplus after investments.
2027 objectives reaffirmed, with further EBITDA margin and cash flow progress expected in 2026.
Financial highlights
Revenues rose 5% year-over-year to €7,296m, with organic growth between 3.7% and 4.1%.
Adjusted EBITDA increased 6% to €1,641m, margin up to 22.5%; reported EBITDA up 8% to €1,561m, margin at 21.4%.
Basic EPS up 24% to €2.31; net profit up 17% to €473m.
Free cash flow to the firm before investment in owned sites up 12% to €1,071m.
Over €1.5bn returned to shareholders since 2021, including €540m in share buybacks in 2025.
Outlook and guidance
FY 2026 targets mid-single-digit organic growth and €250m in annualized acquisition revenues.
Adjusted EBITDA margin expected to improve further, with SDI at EBITDA level to decline.
2027 objectives reaffirmed: 6.5%+ organic growth, 24% adjusted EBITDA margin, SDI at 0.5% of revenues, and cash conversion above 50%.
CapEx to remain around €400m/year, with €200m/year for owned sites in 2026–2027; major IT investments to wind down post-2027.
Free cash flow and cash conversion expected to grow, supporting M&A and shareholder returns.
Justify the capital allocation to owned sites
When do all start-ups turn EBITDA positive?
What headwinds will persist into 2026?
BioPharma Central Lab contract timing and impact
IT transformation: When will benefits fully accrue?
Capital allocation: Buybacks vs. M&A strategy
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- DNLM
Sales up 3.8% to £1,771m, profit before tax £211m, digital sales 40%, market share 7.9%. - 9412
Profits and equity improved, with upward revisions to full-year forecasts and new subsidiaries added. - NVDA
AI is transforming enterprises by enabling intent-driven innovation and technology-first strategies. - DNLMH1 sales up 3.6% to £926m; digital mix 41%; PBT to hit lower end of consensus.
- CRW
Double-digit growth, strong cash flow, and new leadership drive confidence for FY25. - 7011
Strong revenue and profit growth in FY2025, with raised guidance and key divestiture impact. - 8053
Profit attributable to owners dipped 1.9% despite higher revenues and strong FX gains. - 323410
Strong growth in customers, profits, and deposits, with stable asset quality and global milestones. - 3407
Net income rose 22.7% year-over-year, with improved financials and a revised upward forecast. - RYM
Refreshed strategy targets NZD 150m cash flow uplift, NZD 500m cash release, and resumed dividends by FY 2028.
Next Eurofins Scientific earnings date
Q1 202622 Apr, 2026
Eurofins Scientific
Next Eurofins Scientific earnings date
Q1 202622 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Global Laboratories
Eurofins Scientific is a French company that specializes in bio-analytical testing, providing a broad range of services across various industries. The company has global operations and specializes in food, environmental, pharmaceutical, and cosmetics product testing, alongside agriscience, genomics, discovery pharmacology, and central laboratory services. The company operates a vast network of laboratories across the world and offers its services to a wide array of customers in different industries. The company is headquartered in Luxembourg, and its shares are listed on Euronext Paris.
Growing Through Acquisitions
The company was founded in 1987 and started with four employees. The company initially focused on food product testing and over the years, Eurofins expanded both its service offerings and geographic footprint. Eurofins diversified into environmental testing in the 1990s, and later into pharmaceutical and cosmetic product testing. The company acquired various laboratories and smaller companies at a rapid pace both in the years before and after its IPO in 1997.
A Network of Laboratories
The rate of acquisitions remained high going into the new millennium and onwards, and today the company operates over 900 laboratories worldwide. The company can be categorized as a serial acquirer, and for several years during the 2010s acquired over 50 companies and laboratory groups. Said laboratories are spread out across 60 different countries across the globe, allowing Eurofins Scientific to offer its services close to where its customers are located. Some public companies that are similar to Eurofins Scientific are SGS, Intertek, and Bureau Veritas.
What it Does
The company offers over 200,000 validated analytical methods, catering to diverse needs in characterizing the safety, identity, purity, composition, authenticity, and origin of products and biological substances. This wide-ranging portfolio allows Eurofins to serve multiple sectors, including food, environmental, pharmaceutical, and cosmetics industries. Besides this, the company also offers various authentication services that can identify counterfeit food and beverage products, including things such as fine wines and expensive cigars.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage